Keyphrases
Acute Myeloid Leukemia
100%
Isocitrate Dehydrogenase mutation
100%
HOXA9
100%
Leukemia Model
100%
Hypoxia Signaling
100%
MEIS1
100%
IDH mutation
66%
Mutant Isocitrate Dehydrogenase
50%
Mouse Model
16%
Anticancer Agents
16%
Glioma
16%
Dysregulation
16%
Dioxygenase
16%
Anticancer Therapy
16%
Isocitrate Dehydrogenase 1 (IDH1)
16%
Promising Target
16%
Cancer Therapy
16%
Leukemia Stem Cells
16%
α-ketoglutarate (α-KG)
16%
Oncometabolite
16%
2-Hydroxyglutarate (2-HG)
16%
Cre-loxP
16%
Isocitrate
16%
Histone Demethylase
16%
Leukemia Mice
16%
Dehydrogenase Enzyme
16%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse Model
100%
Hypoxia
100%
Acute Myeloid Leukemia
100%
Isocitrate Dehydrogenase
100%
Malignant Neoplasm
33%
Anticarcinogen
16%
Side Effect
16%
Leukemia
16%
Oxidoreductase
16%
Isocitrate Dehydrogenase 1
16%
Dioxygenase
16%
2 Hydroxyglutaric Acid
16%
Histone Demethylase
16%
Isocitric Acid
16%
Isocitrate Dehydrogenase 2
16%